Research has led to greater understanding of the disease, potential for better treatment options
ACR Winter Rheumatology Symposium: Answers to Your Tough Questions about Rheumatic Disease Therapy
Panelists discuss vaccination, biologics and infection, methotrexate, cardiovascular risk, and serial immunoglobulin testing and imaging
ACR Winter Rheumatology Symposium: New Kinase Inhibitors Show Promise
Toxicity and appropriate targeting are challenges for small molecule researchers
Legal Updates: What Rheumatologists Should Consider Before Signing with an ACO
Medicare’s ACO physician exclusivity provisions may preclude participation in more than one accountable care organization
Large Genome Study Identifies Genetic Risk Factors for Gout
Researchers have identified 28 genome-wide significant urate concentration–associated loci, underscoring the importance of metabolic control in urate production.
Sequester Affects Rheumatologists on Two Fronts—Medicare Reimbursement and Research Funding
Rheumatologists are already feeling two effects from Congress’ inability to solve sequestration: a 2% reduction in Medicare reimbursements and slashed funding for research financed by the National Institutes of Health.
DNA Methylation Modifies Genetic Risk for Rheumatoid Arthritis
A first-of-its-kind study has been published that integrates genotype and epigenotype data across the entire genome.
President’s Perspective: ACR Calls on Members to Advance Rheumatology
Members’ support and participation is needed to strengthen the ACR’s lobbying efforts with Congress
How Rheumatologists Can Win Support and Influence Congress
Ways to use the ACR’s advocacy toolkit to contact Congressional representatives and articulate your message to lawmakers
Award Recipient Advances Rheumatology Education with e-Learning Tools
With a grant from the ACR’s Rheumatology Research Foundation, Christopher Collins, MD, is supplying e-learning tools for use in rheumatology education
- « Previous Page
- 1
- …
- 234
- 235
- 236
- 237
- 238
- …
- 300
- Next Page »